Phenylpiperazine

Phenylpiperazine

SCHEMBL28478038

O=P(O)(O)O.c1ccc(N2CCNCC2)cc1

nearest known ligand 0.77

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

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

The experimentally established mechanism targets of Phenylpiperazine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ADRB1 known ✓ P08588 6/20 0.77
▸ ADRB2 known ✓ P07550 1/20 0.50
▸ HTR3E A5X5Y0 4/20 0.77
▸ HTR3B O95264 4/20 0.77
▸ HTR3A P46098 4/20 0.77
▸ HTR3D Q70Z44 4/20 0.77
▸ HTR3C Q8WXA8 4/20 0.77
▸ SIGMAR1 Q99720 4/20 0.77
▸ USP2 O75604 2/20 0.62
▸ ALDH1A1 P00352 2/20 0.62
▸ TSHR P16473 1/20 0.62
▸ HSD17B10 Q99714 1/20 0.62
▸ HTR6 P50406 4/20 0.57
▸ HTR1A P08908 2/20 0.56
▸ HTR7 P34969 2/20 0.56
▸ LTA4H P09960 1/20 0.56
▸ CYP2D6 P10635 2/20 0.53
▸ HTR2C P28335 2/20 0.53
▸ TP53 P04637 1/20 0.53
▸ CYP1A2 P05177 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Phenylpiperazine SCHEMBL11621472 0.88 ADRB1 (0.83) ADRB1HTR3EHTR3BHTR3AHTR3D
Phenylpiperazine SCHEMBL29135595 0.88 ADRB1 (1.00) ADRB1HTR3EHTR3BHTR3AHTR3D
Phenylpiperazine SCHEMBL27858598 0.88 ADRB1 (1.00) ADRB1HTR3EHTR3BHTR3AHTR3D
Phenylpiperazine SCHEMBL55125 0.88 ADRB1 (1.00) ADRB1HTR3EHTR3BHTR3AHTR3D
Phenylpiperazine SCHEMBL24889 0.88 ADRB1 (1.00) ADRB1HTR3EHTR3BHTR3AHTR3D
Phenylpiperazine SCHEMBL27492626 0.86 ADRB1 (0.87) ADRB1HTR3EHTR3BHTR3AHTR3D
Phenylpiperazine SCHEMBL4828251 0.86 ADRB1 (0.87) ADRB1HTR3EHTR3BHTR3AHTR3D
Phenylpiperazine SCHEMBL10675573 0.86 ADRB1 (0.95) ADRB1HTR3EHTR3BHTR3AHTR3D
Phenylpiperazine SCHEMBL212247 0.86 ADRB1 (0.95) ADRB1HTR3EHTR3BHTR3AHTR3D
SCHEMBL17431870 0.86 ADRB1 (0.95) ADRB1HTR3EHTR3BHTR3AHTR3D

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114561083-A Preparation method of piperazinyl phenylphosphate flame-retardant epoxy resin composite material 南京工业大学 2022-05-31 — — CN claimed
CN-112526026-A Method for detecting chemical component addition in Chinese patent medicine 北京美康堂医药科技有限公司 2021-03-19 — — CN claimed
CN-114561083-A Preparation method of piperazinyl phenylphosphate flame-retardant epoxy resin composite material 南京工业大学 2022-05-31 — — CN disclosed
CN-114561083-A Preparation method of piperazinyl phenylphosphate flame-retardant epoxy resin composite material 南京工业大学 2022-05-31 — — CN disclosed
CN-114129527-A Miniature tablet and preparation method and preparation thereof 北京微智瑞医药科技有限公司 2022-03-04 — — CN disclosed
CN-113788757-B Pentoxyverine citrate hapten, antigen, antibody, detection device and preparation method 广东江门中医药职业学院 2022-02-18 — — CN disclosed
CN-113788757-A Pentoxyverine citrate hapten, antigen, antibody, detection device and preparation method 广东江门中医药职业学院 2021-12-14 — — CN disclosed
CN-111902146-A Medicinal product for treating cough 日本化学药品株式会社 2020-11-06 — — CN disclosed
Send feedback